- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.06. | BBNX Stock May Gain From Abbott Deal to Advance iLet Integration | 2 | Zacks | ||
| 23.06. | Beta Bionics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.06. | Analysts expect Beta Bionics patch pump launch by 2027 | 4 | MassDevice | ||
| 19.06. | Beta Bionics to pair iLet automated insulin delivery system with Abbott's dual glucose-ketone sensor | 2 | MassDevice | ||
| 19.06. | Beta Bionics, Inc.: Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor | 162 | GlobeNewswire (Europe) | IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet... ► Artikel lesen | |
| 16.06. | Beta Bionics stock initiated with Buy rating at Truist Securities | 5 | Investing.com | ||
| BETA BIONICS Aktie jetzt für 0€ handeln | |||||
| 01.06. | Wolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform Rating | 2 | Insider Monkey | ||
| 30.05. | Goldman Sachs stuft Beta Bionics-Aktie mit Neutral-Rating und Kursziel von 16 US-Dollar ein | 5 | Investing.com Deutsch | ||
| 30.05. | Goldman Sachs sets Beta Bionics stock at Neutral with $16 target | 2 | Investing.com | ||
| 07.05. | Beta Bionics Q1 2025 slides: raised guidance despite earnings miss | 3 | Investing.com | ||
| 06.05. | Beta Bionics GAAP EPS of -$0.93 misses by $0.46, revenue of $17.6M beats by $1.45M | 2 | Seeking Alpha | ||
| 06.05. | Beta Bionics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 06.05. | Beta Bionics, Inc.: Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 | 496 | GlobeNewswire (Europe) | IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results... ► Artikel lesen | |
| 16.04. | Beta Bionics, Inc.: Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 | 1 | GlobeNewswire (USA) | ||
| 09.04. | Beta Bionics, Inc.: Beta Bionics to Host Investor Event on June 22, 2025 | 2 | GlobeNewswire (USA) | ||
| 04.04. | Stifel maintains Buy rating on Beta Bionics stock, target at $25 | 6 | Investing.com | ||
| 28.03. | Beta Bionics, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 27.03. | Beta Bionics appoints new board member from Delcath Systems | 1 | Investing.com | ||
| 27.03. | Beta Bionics ernennt neues Vorstandsmitglied von Delcath Systems | 4 | Investing.com Deutsch | ||
| 27.03. | Beta Bionics, Inc.: Beta Bionics Announces Board Appointment of Gerard Michel | 1 | GlobeNewswire (USA) |
1 2 3 4 Weiter >>
62 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,710 | -0,74 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| NUTEX HEALTH | 124,49 | 0,00 % | Nutex Health added to Russell 3000 and Russell Microcap Index | ||
| FRESENIUS MEDICAL CARE | 48,420 | -0,02 % | Aktien im Fokus: Stimmungsumschwung bei Nvidia, Analysten zurückhaltend bei FMC, De.mem erwartet Boom bei Wasseraufbereitung | ||
| PRIVIA HEALTH GROUP | 23,010 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 23,590 | 0,00 % | TD Cowen Begins Coverage of BrightSpring Health Services (BTSG) Stock, Gives Buy | ||
| FRESENIUS | 42,360 | -0,80 % | Aktienmarkt: Fresenius SE & Co. KGaA-Aktie kann sich nicht behaupten (42,16 €) | Der Anteilsschein von Fresenius SE & Co. KGaA notiert am Mittwoch leichter. Die Aktie kostete zuletzt 42,16 Euro. Für Inhaber von Fresenius+Co KgaA ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
| NEUROPACE | 11,140 | 0,00 % | NeuroPace, Inc.: NeuroPace Announces Strategic CFO Transition | Appoints Patrick F. Williams as Chief Financial Officer Williams Brings a Track Record of Leading Medical Device Public Companies as CFO Rebecca Kuhn Departing Company and Will Remain in Advisory... ► Artikel lesen | |
| LIFEMD | 13,620 | 0,00 % | Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside? | ||
| GENEDX | 92,23 | 0,00 % | Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts | ||
| ALIGNMENT HEALTHCARE | 13,995 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| PROGYNY | 21,995 | 0,00 % | Here's Why Progyny (PGNY) Rebounded in Q1 | ||
| PROCEPT BIOROBOTICS | 57,65 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| OMADA HEALTH | 18,190 | 0,00 % | JPMorgan initiates Omada Health stock with Overweight rating on GLP-1 opportunity | ||
| CARL ZEISS MEDITEC | 55,80 | 0,00 % | Carl Zeiss Meditec AG: Chirurgische Präzision, strategische Genauigkeit; mwb research stuft auf KAUFEN | Carl Zeiss Meditec (CZM) bleibt ein weltweit führender Anbieter in der Augenheilkunde und Mikrochirurgie, gestützt durch strukturelle Wachstumstreiber wie demografischen Wandel und die Zunahme von Sehstörungen.... ► Artikel lesen | |
| RXSIGHT | 12,980 | 0,00 % | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |
Das Unternehmen BETA BIONICS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 14,570 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BETA BIONICS INC finden Sie auf Wallstreet Online.